Ameen, Ahmed http://orcid.org/0009-0002-7371-4509
Dhaheri, Ahmed Al
Reda, Ashraf M.
Alnaeem, Ayman
Marzooqi, Fatima Al http://orcid.org/0009-0002-4724-8225
Albreiki, Fatima http://orcid.org/0009-0003-8831-0969
Ali, Huda Rajab
Dayem, Hussein Abdel
Alnaqbi, Jawaher
Zaabi, Mariam Al
Ahmed, Mohammed
Stingl, Georg http://orcid.org/0000-0003-3843-7841
Murrawi, Muna Al
Funding for this research was provided by:
Emirates Dermatological Society.
Article History
Received: 7 June 2024
Accepted: 26 July 2024
First Online: 22 August 2024
Declarations
:
: Ahmed Ameen has received honorarium as speaker and/or advisor and/or principal investigator from AbbVie, Ego Pharma, Galderma, Janssen, LEO Pharma, Lilly, Novartis, Pfizer, and Sanofi. Hussein Abdel Dayem has received honoraria from Abbvie, Eli Lilly, Janssen, Medpharma, Novartis, Pfizer, Sanofi, and UCB. Georg Stingl has received consultation and/or lecture fees from Almirall, AOP Health, Boehringer Ingelheim, Bristol Myers Squibb, Evommune, LEO Pharma, Lilly, Marinomed AG, Novartis, and Sanofi/Regeneron. Ahmed Al Dhaheri, Ashraf M. Reda, Ayman Alnaeem, Fatima Al Marzooqi, Fatima Albreiki, Huda Rajab Ali, Jawaher Alnaqbi, Mariam Al Zaabi, Mohammed Ahmed, and Muna Al Murrawi have no conflicts of interest to declare.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. Ethical approval was not required.